According to Assertio Therapeutics 's latest financial reports the company's current EPS (TTM) is $2.71. In 2022 the company made an earnings per share (EPS) of $3.10 an increase over its 2021 EPS that were of -$0.02710.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $2.69 | -13.23% |
2022 | $3.10 | -11550% |
2021 | -$0.02710 | -96.08% |
2020 | -$0.69 | -95.79% |
2019 | -$16.42 | -622.41% |
2018 | $3.14 | -135.58% |
2017 | -$8.84 | 13.19% |
2016 | -$7.81 | 13.39% |
2015 | -$6.88 | -156.44% |
2014 | $12.20 | 200% |
2013 | $4.07 | -238.89% |
2012 | -$2.93 | -140.6% |
2011 | $7.21 | 1562.5% |
2010 | $0.43 | -118.6% |
2009 | -$2.33 | 34.38% |
2008 | -$1.73 | -132% |
2007 | $5.42 | -203.09% |
2006 | -$5.26 | 51.56% |
2005 | -$3.47 | -16.88% |
2004 | -$4.17 | -38.4% |
2003 | -$6.78 | 32.98% |
2002 | -$5.10 | -48.35% |
2001 | -$9.87 | 27.27% |
2000 | -$7.75 | 76.54% |
1999 | -$4.39 | 88.37% |
1998 | -$2.33 | 26.47% |
1997 | -$1.84 |